Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Delmer

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Cancer Genetics and Cytogenetics|November 11, 1998
Pentasomy 13q in a case of acute myelogenous leukemia (Mo)S Ramond, V Cacheux, M Ciaudo, et al.
Bulletin Du Cancer|September 1, 1993
[Treatment of high malignancy lymphoma with intensive short-term chemotherapy using the MACOP-B regimen]A Delmer, F Bauduer, A Ruskoné-Fourmestraux, et al.
The American Journal of Surgical Pathology|December 16, 2000
Splenic marginal zone lymphoma with or without plasmacytic differentiationJ P Duong Van Huyen, T Molina, A Delmer, et al.
American Journal of Hematology|June 22, 2000
Relapse after autologous hematopoietic stem cell transplantation in acute myeloid leukemia, a single center experience over 13 yearsV Lévy, Z Marjanovic, A Vekhoff, et al.
Leukemia|October 1, 1995
Glutathione-S-transferases pi, alpha, mu and mdr1 mRNA expression in normal lymphocytes and chronic lymphocytic leukemiaJ P Marie, G Simonin, O Legrand, et al.
Annales De Medecine Interne|January 1, 1990
[Castleman's disease (giant lymph node hyperplasia): clinical, biological and developing polymorphism. Apropos of 4 cases]A Delmer, M Karmochkine, A Le Tourneau, et al.
Bone Marrow Transplantation|December 1, 1989
Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia GroupH H Gerhartz, G Visani, A Delmer, et al.
American Journal of Hematology|June 1, 1992
Acquired von Willebrand disease: correction of hemostatic defect by high-dose intravenous immunoglobulinsA Delmer, M H Horellou, J M Bréchot, et al.
Blood|December 15, 1993
Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemiaS Castaigne, P Lefebvre, C Chomienne, et al.
Blood|October 1, 1993
Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cellsL Delva, M Cornic, N Balitrand, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Cancer Genetics and Cytogenetics|November 11, 1998
Pentasomy 13q in a case of acute myelogenous leukemia (Mo)S Ramond, V Cacheux, M Ciaudo, et al.
Bulletin Du Cancer|September 1, 1993
[Treatment of high malignancy lymphoma with intensive short-term chemotherapy using the MACOP-B regimen]A Delmer, F Bauduer, A Ruskoné-Fourmestraux, et al.
The American Journal of Surgical Pathology|December 16, 2000
Splenic marginal zone lymphoma with or without plasmacytic differentiationJ P Duong Van Huyen, T Molina, A Delmer, et al.
American Journal of Hematology|June 22, 2000
Relapse after autologous hematopoietic stem cell transplantation in acute myeloid leukemia, a single center experience over 13 yearsV Lévy, Z Marjanovic, A Vekhoff, et al.
Leukemia|October 1, 1995
Glutathione-S-transferases pi, alpha, mu and mdr1 mRNA expression in normal lymphocytes and chronic lymphocytic leukemiaJ P Marie, G Simonin, O Legrand, et al.
Annales De Medecine Interne|January 1, 1990
[Castleman's disease (giant lymph node hyperplasia): clinical, biological and developing polymorphism. Apropos of 4 cases]A Delmer, M Karmochkine, A Le Tourneau, et al.
Bone Marrow Transplantation|December 1, 1989
Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia GroupH H Gerhartz, G Visani, A Delmer, et al.
American Journal of Hematology|June 1, 1992
Acquired von Willebrand disease: correction of hemostatic defect by high-dose intravenous immunoglobulinsA Delmer, M H Horellou, J M Bréchot, et al.
Blood|December 15, 1993
Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemiaS Castaigne, P Lefebvre, C Chomienne, et al.
Blood|October 1, 1993
Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cellsL Delva, M Cornic, N Balitrand, et al.
Pageof 12